Showing 1 - 2 results of 2 for search 'Yuto Hiramoto', query time: 0.02s Refine Results
  1. 1
    Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation

    Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation by Kento Nishida, Hiroshi Watanabe, Ryota Murata, Kai Tokumaru, Rui Fujimura, Shun Oshiro, Taisei Nagasaki, Masako Miyahisa, Yuto Hiramoto, Hiroto Nosaki, Tadashi Imafuku, Hitoshi Maeda, Masafumi Fukagawa, Toru Maruyama

    Published 2021-05-01
    Get full text
    Article
  2. 2
    An acute phase protein α1-acid glycoprotein mitigates AKI and its progression to CKD through its anti-inflammatory action

    An acute phase protein α1-acid glycoprotein mitigates AKI and its progression to CKD through its anti-inflammatory action by Hiroshi Watanabe, Rui Fujimura, Yuto Hiramoto, Ryota Murata, Kento Nishida, Jing Bi, Tadashi Imafuku, Hisakazu Komori, Hitoshi Maeda, Ayumi Mukunoki, Toru Takeo, Naomi Nakagata, Motoko Tanaka, Kazutaka Matsushita, Masafumi Fukagawa, Toru Maruyama

    Published 2021-04-01
    Get full text
    Article

Search Tools: